Skip to content
The Nexus
HEALTHJul 14 · 17:53 UTCMEDPAGE TODAY

Push for Cath Lab Safety; Eplontersen Flops in ATTR-CM; Off-Label Testosterone Risks

A multisociety expert consensus statement advocates for enhanced radiation protection in cath labs. Eplontersen failed in trials for ATTR-CM, and off-label testosterone use is linked to risks.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
multisociety expert consensustopicJohnson & JohnsonorganizationEplontersentopicATTR-CMtopicTestosteronetopiccath lab operatorstopicFDAorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting

Push for Cath Lab Safety; Eplontersen Flops in ATTR-CM; Off-Label Testosterone Risks · The Nexus